↓ Skip to main content

American Association for Cancer Research

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Overview of attention for article published in Cancer Discovery, September 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
20 news outlets
blogs
2 blogs
twitter
13 X users
patent
29 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
1670 Dimensions

Readers on

mendeley
765 Mendeley
Title
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Published in
Cancer Discovery, September 2014
DOI 10.1158/2159-8290.cd-14-0337
Pubmed ID
Authors

Darren A.E. Cross, Susan E. Ashton, Serban Ghiorghiu, Cath Eberlein, Caroline A. Nebhan, Paula J. Spitzler, Jonathon P. Orme, M. Raymond V. Finlay, Richard A. Ward, Martine J. Mellor, Gareth Hughes, Amar Rahi, Vivien N. Jacobs, Monica Red Brewer, Eiki Ichihara, Jing Sun, Hailing Jin, Peter Ballard, Katherine Al-Kadhimi, Rachel Rowlinson, Teresa Klinowska, Graham H.P. Richmond, Mireille Cantarini, Dong-Wan Kim, Malcolm R. Ranson, William Pao

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 765 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Japan 2 <1%
Korea, Republic of 1 <1%
United Kingdom 1 <1%
Denmark 1 <1%
France 1 <1%
Iran, Islamic Republic of 1 <1%
Spain 1 <1%
Unknown 755 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 144 19%
Student > Ph. D. Student 123 16%
Student > Bachelor 81 11%
Student > Master 77 10%
Other 48 6%
Other 121 16%
Unknown 171 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 142 19%
Medicine and Dentistry 126 16%
Agricultural and Biological Sciences 98 13%
Chemistry 87 11%
Pharmacology, Toxicology and Pharmaceutical Science 71 9%
Other 47 6%
Unknown 194 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 164. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2023.
All research outputs
#249,296
of 25,410,626 outputs
Outputs from Cancer Discovery
#91
of 4,072 outputs
Outputs of similar age
#2,119
of 248,616 outputs
Outputs of similar age from Cancer Discovery
#2
of 65 outputs
Altmetric has tracked 25,410,626 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,072 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,616 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.